Clinical Drug Experience Knowledgebase

acetylsalicylic acid (aspirin) (1 trial)

basiliximab (Simulect) (1 trial)

betamethasone (celestone) (2 trials)

clopidogrel (plavix) (1 trial)

deng zhan sheng mai (1 trial)

dexmedetomidine (precedex) (1 trial)

dydrogesterone (gynorest) (1 trial)

eltrombopag (promacta) (1 trial)

estradiol (progynon depot) (1 trial)

glucose (1 trial)

hydroquinone (1 trial)

kuntai (1 trial)

methylprednisolone (medrol) (1 trial)

musk (1 trial)

nafamostat (ronastat) (1 trial)

rituximab (rituxan) (2 trials)

rivaroxaban (xarelto) (1 trial)

ropivacaine (naropin) (3 trials)

sodium chloride (1 trial)

somatropin (protropin) (1 trial)

valsartan (diovan) (1 trial)

vedolizumab (entyvio) (1 trial)

alteplase (Activase) (2 trials)

bat5906 (1 trial)

cetuximab (erbitux) (1 trial)

colchicine (colbenemid) (1 trial)

cyclophosphamide (cytoxan) (2 trials)

dexamethasone (1 trial)

doxorubicin (Doxil) (1 trial)

Epimedium (2 trials)

huachansu pian (1 trial)

irinotecan (Camptosar) (1 trial)

lenalidomide (revlimid) (2 trials)

prednisone (meticorten) (2 trials)

ranibizumab (lucentis) (2 trials)

sorafenib (nexavar) (1 trial)

vincristine (oncovin) (1 trial)

zanubrutinib (Brukinsa) (1 trial)

abiraterone (zytiga) (1 trial)

acetaminophen (tylenol) (1 trial)

autologous cd19/cd22 chimeric antigen receptor t-cells (1 trial)

autologous hematopoietic stem cells (1 trial)

azacitidine (vidaza) (4 trials)

chidamide (1 trial)

cisplatin (platinol) (1 trial)

cladribine (leustatin) (2 trials)

cytarabine (cytosar-u) (2 trials)

dalpiciclib (2 trials)

Efbemalenograstim alpha (Ryzneuta) (1 trial)

epirubicin (ellence) (1 trial)

fluorouracil (efudex) (1 trial)

fluzoparib (1 trial)

fulvestrant (faslodex) (2 trials)

gefitinib (iressa) (2 trials)

genakumab (1 trial)

inotuzumab ozogamicin (besponsa) (1 trial)

lapatinib (tykerb) (1 trial)

mannitol (Osmitrol) (1 trial)

sargramostim (leukine) (1 trial)

venetoclax (venclexta) (6 trials)

hcd19.il15.car-inkt (1 trial)

metformin (glucophage) (1 trial)

orlistat (xenical) (1 trial)

pioglitazone (actos) (1 trial)

platelet-rich plasma (1 trial)

tang ning tongluo (1 trial)

anlotinib (1 trial)

axitinib (inlyta) (1 trial)

gabapentin (neurontin) (1 trial)

icotinib (Conmana) (1 trial)

lidocaine (xylocaine) (1 trial)

pazopanib (votrient) (1 trial)

pregabalin (lyrica) (1 trial)

resveratrol (1 trial)

sunitinib (sutent) (1 trial)

vitamin e (1 trial)

xingnaojing (1 trial)